Summary.-Phorbol, the unesterified parent alcohol of the skin promoter TPA, was administered i.p., twice weekly, throughout the lifetime of mice of 7 inbred strains: males and females of AKR/J, C3Heb and BALB/c, and females of SJL/J, DBA/2, SWR and C57BL. A striking difference in strain response was observed, with a pronounced leukaemogenic effect in SWR, a significant shortening of the latent period for spontaneous reticulum cell sarcomas (RCNB) in SJL/J, and no demonstrable effect in the other strains. When mice of 3 of the above-mentioned strains (SWR, SJL/J and AKR/J) were thymectomized prior to the beginning of phorbol treatment, different patterns of response were again observed. Thymectomy did not influence the leukaemia incidence in SWR mice, slightly inhibited RCNB development in SJL/J mice and converted phorbol into a leukaemogenic agent for AKR/J mice.
FOLLOWING the establishment of the two-stage mechanism of skin carcinogenesis, with croton oil as promoting agent, a number of attempts have been made to discover whether a similar mechanism was operative in tissues other than skin, and to identify some of the substances capable of such systemic initiation and promotion (Berenblum, 1975) .
In the case of skin, the effective promoter, isolated from croton oil, was identified as 1 2-0-tetradecanoyl-phorbol-13-acetate (TPA) (Hecker, 1968; Van Duuren, 1969) . Though the unesterified parent alcohol, phorbol, was first claimed to be entirely inlactive as promoter for skin carcinogenesis (Hecker, 1966) , and subsequently found to possess weak or borderline promoting action for this tissue, under special conditions (Baird and Boutwell, 1971; Armuth and Berenblum, 1976) , it proved to be an effective promoter for lung, liver and mammary carcinogenesis Berenblum, 1972, 1974) .
In the course of these studies on systemic promoting action, it was found that phorbol was also a potent leukaemogenic agent, producing non-thymic leukaemia in SWR mice (Berenblum and Lonai, 1970) and thymic lymphomas in Wistar rats (Armuth and Berenblum, 1974) .
Since strain differences in response to systemic carcinogenesis are known to be sometimes quite pronounced (Weisburger and Weisburger, 1967) , and also in leukaemogenesis (Upton and Furth, 1957) made between the leukaemia incidences in intact and phorbol-treated, as well as in intact and thymectomized mice, the x2 test being used for the determination of statistical significance.
RESULTS

A. Leukaemogenesis
The leukaemogenic effect of phorbol in SWR mice-the only strain which responded strongly has alreadv been reported earlier (Berenblum and Lonai, 1.970), and was now confirmed in a repeat experiment: 29/39 (740o) of the mice developing lymphatic leukaemias as a result of phorbol treatment, with an average latent period of 216 days from birth (Table I) . Of these, only 3 mice showed thymic involvement, according to the macro-and microscopic examination.
In the case of SJL/J mice, no lymphatic leukaemias were induced by chronic phorbol treatment, but the spontaneous development of reticulum cell neoplasms type B (RCNB), characteristic of the strain, was significantly enhanced, as shown by the shortening of the latent period (Fig. 1) (Table 1) , and the spontaneous leukaemia incidence was also 000. Some of the mice received 2 x 170 rad whole body Xirradiation, in an attempt to break through the immunological barrier of this strain, but even in this case no significant excess of leukaemias could be detected with Xirradiation plus phorbol treatment, compared to X-irradiation only (0.20 < P < 0.30) ( Table I) .
In AKR/J mice, the spontaneous lymphatic leukaemia incidence was already high (15/15 100% in females, with an average latent period of 324 days from birth, and 10/14 71% in males, with a latent period of 304 days). Phorbol did not alter either the incidence or the latent period of the leukaemias. As summarized in Table I (Armuth and Berenblum, 1972) .
No lymphoreticular diseases of any kind developed, during more than a year's observation, in C3Heb, BALB/c and DBA/2 mice, in response to phorbol (Table I ). The spontaneous occurrence of leukaemias in these strains is also very low or non-existent.
B. Effect of thymectomy
Thymectomy prior to phorbol treatment did not alter the pattern of leukaemia induction in SWR mice. In the thymectomized phorbol-treated group, 32 mice out of 38 (84%) developed lymphatic leukaemias, as against the 74% incidence in intact mice. Four additional cases of myeloid leukaemia ( 11 %) and two of reticulum cell sarcoma (5%) were observed. Fig. 2 shows the rate of leukaemia development in these 2 groups. Judging from the shape of the curves, a difference in leukaemia development between the thymectomized and non-thymectomized mice might be suggested, but the total incidences were nearly the same, and the average latent periods did not differ either.
In SJL/J mice, thymectomy affected RCNB development both in the untreated and in the phorbol-treated group (Fig. 1) period 393 days). The incidence in the phorbol-treated group was influenced the same way. While in the intact mice after phorbol treatment 82% of the animals (27/33) developed RCNB (average latent period 284 days), thymectomy one week prior to the beginning of the treatment reduced this incidence to 56% (19/34: average latent period 341 days). This inhibitory effect cannot, however, be considered significant (0.05 < P < 0-10 for the untreated and P , 0.02 for the phorbol-treated groups, respectively). Thymectomy at an early age (less than one month) decreased the high spontaneous incidence of lymphatic leukaemias in AKR/J mice from 100% for females and The leukaemias developing in thymectomized AKR/J mice were mostly lymphatic, although no traces of thymic tissue could be found either by gross examination or microscopically. Three additional myeloid leukaemias developed in the phorbol-treated females, and one case each in the untreated and phorbolinjected males.
DISCUSSION
The crucial outcome of this enquiry is the fact that phorbol is so potent a leukaemogenic agent for SWR mice, but almost entirely devoid of such action in the other strains of mice tested. In trying to find an explanation for this, it is worth examining how these various strains respond to other forms of leukaemogenic action.
Strains C3Heb and BALB/c are known to respond poorly to chemical leukaemogenesis (Upton and Furth, 1957) , thus paralleling the results with phorbol (though in the latter case, the response was completely negative). No such parallelism seems to exist for the other strains tested.
In the case of C57BL mice, X-irradiation is a very effective inducer of leukaemias (Kaplan, 1964) , while urethane can also act as a leukaemogenic agent (Doell and Carnes, 1962 ). Yet phorbol treatment did not reveal any leukaemogenic activity in this strain. In one group, the phorboltreated mice were also irradiated, taking into account the known immunosuppressive properties as well as the leukaemogenic action of X-irradiation in this strain. Its combination with phorbol did not, however, significantly increase the incidence of radiation-induced leukaemias. Thus the possibility of syncarcinogenic action between these two factors can be excluded. DBA/2 mice, which reveal no spontaneous leukaemia incidence, are nevertheless susceptible to lymphoma induction both by chemical carcinogens and Xirradiation (Chen and Berenblum, 1968) . The failure of phorbol to produce leukaemia in this strain is therefore yet another example of how critical the choice of strain is in relation to different carcinogens. (Dunn, 1954) . Dimethylbenzanthracene feeding induces lymphosarcomas in this strain, while X-irradiation produces either lymphatic or myeloid leukaemias, depending on the dose and the schedule of irradiation (Haran-Ghera, Kotler and Meshorer, 1967) . In the present experiment, i.p. phorbol injections caused no more than an acceleration of RCNB development. Histological examination of each case showed that the proportion of plasma cells in the tumours of phorbolinjected mice had increased significantly (Table III) , thus suggesting a mechanism similar to that of i.p. mineral oil injections (Ben-Yaakov, 1974) .
In AKR/J mice, phorbol treatment did not affect the pattern of spontaneous (viral) leukaemia development: analogous to the results of Gericke, Kovac and Hecker (1974) , who failed to induce leukaemias by i.p. phorbol administration in their AKR subline, in which spontaneous leukaemia incidence is extremely low.
There are many known examples of species and even strain differences in response to carcinogenic stimuli, attributable to different pathways of metabolizing the compound or to a detoxication process in one species and its lack in others (Weisburger and Williams, 1975) , with evidence of corresponding variations in enzyme activity (Kuori, Ratrie and Whitmire, 1973 mice, the results confirmed previous morphological evidence that the thymus did not take part in the induction and development of the leukaemias. The suggested explanation is that only bonemarrow-derived lymphocytes participate in this form of leukaemogenesis (HaranGhera and Peled, 1973; Dexter et al., 1974) . In the SJL/J mice, thymectomy possibly had a slight inhibitory effect in both the control and the phorbol-treated mice, the resitlts corresponding well with previous findings by Haran-Ghera et al., (1967) . The lack of a real inhibition by thymectomy suggests a mechanism, proposed by Lamon et al. (1973) , that immune surveillance is a function of non-thymusderived cells, or that it is a function of a highly specialized T-cell subpopulation which remains intact after thymectomy (Gillette and Fox, 1975) .
Removal of the thymus in AKR mice is known to reduce drastically the spontaneous leukaemia incidence (McEndy, Boon and Furth, 1944) . This was confirmed in the present experiment. But when phorbol was injected to the thvmectomized mice, lymphatic leukaemias occurred in a fairly high percentage, especially in the males. Greenberg and Zatz (1975) have reported a few cases of spontaneous lymphoma in AKR mice older than one year, which had been thymectomized at one month of age. These leukaemias showed B-cell characteristics, which might be explained by the in vivo transformation and differentiation of the lymphoid cells into a double-marker cell population. These alternative suggestions to explain the strain differences in phorbol leukaemogenesis and the effect of thymectomy in the present system should provide a lead to further experimental exploration.
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